Fudan University Cancer hospital

Shanghai, Shanghai Municipality 200032

0 studies enrolling now · 2 studies all time

What they study most

HER2 Exon 20 Mutation, Non-squamous NSCLC, Prostate Cancer

Studies at this site

• Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC — Running, not enrolling
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed